Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,018
Closed -$274K 3
2025
Q2
$274K Buy
2,018
+208
+11% +$27.4K 0.05% 201
2025
Q1
$240K Buy
+1,810
New +$230K 0.05% 197
2022
Q2
Sell
-2,118
Closed -$250K 246
2022
Q1
$250K Sell
2,118
-452
-18% -$56K 0.06% 224
2021
Q4
$363K Hold
2,570
0.08% 205
2021
Q3
$304K Hold
2,570
0.08% 219
2021
Q2
$298K Hold
2,570
0.08% 219
2021
Q1
$307K Hold
2,570
0.08% 217
2020
Q4
$282K Buy
+2,570
New +$279K 0.08% 213
2020
Q2
$241K Buy
+2,639
New +$239K 0.09% 182
2020
Q1
Sell
-2,373
Closed -$205K 199
2019
Q4
$205K Hold
2,373
0.08% 214
2019
Q3
$200K Buy
+2,373
New +$202K 0.08% 214

Other funds holding ABT

Summit X LLC's ABT Position: Q3 2025 in Review

Summit X LLC sold out of Abbott (ABT) in Q3 2025, closing a stake of 2,018 shares — an estimated $274K sold.

Summit X LLC first reported a position in ABT in Q3 2019 and held it in 11 quarters. The position peaked at $363K in Q4 2021. 3,180 funds tracked by Wall St. Rank hold ABT as of Q3 2025.

  • Summit X LLC reported no remaining Abbott position as of Q3 2025 after selling out during the quarter.
  • Summit X LLC sold 2,018 Abbott shares in Q3 2025, an estimated $274K.
  • Summit X LLC first reported a position in Abbott in Q3 2019 and held it in 11 quarters.
  • Summit X LLC's Abbott position peaked at $363K in Q4 2021.
  • 3,180 funds tracked by Wall St. Rank held Abbott as of Q3 2025.

Based on Summit X LLC's 13F filing for Q3 2025.